ALZAMEND Trademark

Trademark Overview

On Wednesday, June 29, 2022, a trademark application was filed for ALZAMEND with the United States Patent and Trademark Office. The USPTO has given the ALZAMEND trademark a serial number of 97482161. The federal status of this trademark filing is REGISTERED as of Tuesday, September 16, 2025. This trademark is owned by Alzamend Neuro, Inc.. The ALZAMEND trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of psychiatric and neurological disorders and diseases
alzamend

General Information

Serial Number97482161
Word MarkALZAMEND
Filing DateWednesday, June 29, 2022
Status700 - REGISTERED
Status DateTuesday, September 16, 2025
Registration Number7950424
Registration DateTuesday, September 16, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of psychiatric and neurological disorders and diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 19, 2022
Primary Code005
First Use Anywhere DateMonday, April 7, 2025
First Use In Commerce DateMonday, April 7, 2025

Trademark Owner History

Party NameAlzamend Neuro, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30326
Party NameAlzamend Neuro, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30326
Party NameAlzamend Neuro, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30326

Trademark Events

Event DateEvent Description
Saturday, July 2, 2022NEW APPLICATION ENTERED
Tuesday, July 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 12, 2023ASSIGNED TO EXAMINER
Thursday, April 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 16, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, January 26, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 5, 2024DIVISIONAL PROCESSING COMPLETE
Thursday, January 11, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 11, 2024SOU EXTENSION 1 FILED
Thursday, January 11, 2024SOU EXTENSION 1 GRANTED
Saturday, January 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 25, 2024DIVISIONAL REQUEST RECEIVED
Thursday, January 25, 2024TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, July 10, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 6, 2024CORRECTED NOA E-MAILED
Tuesday, January 7, 2025SOU EXTENSION 3 FILED
Monday, March 17, 2025SOU EXTENSION 3 GRANTED
Tuesday, March 18, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 11, 2025USE AMENDMENT FILED
Friday, July 11, 2025TEAS STATEMENT OF USE RECEIVED
Friday, August 15, 2025STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 27, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, August 27, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 16, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, September 16, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 7, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, July 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 10, 2024SOU EXTENSION 2 GRANTED
Wednesday, July 10, 2024SOU EXTENSION 2 FILED

Related Keywords

alzamend neurological disorders diseases psychiatric treatment preparations substances pharmaceutical